Short Interest in ReWalk Robotics Ltd. (NASDAQ:LFWD) Decreases By 5.9%

ReWalk Robotics Ltd. (NASDAQ:LFWD) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 188,100 shares, a drop of 5.9% from the September 30th total of 199,800 shares. Approximately 2.7% of the company’s stock are sold short. Based on an average daily trading volume, of 36,800 shares, the short-interest ratio is presently 5.1 days.

ReWalk Robotics Trading Up 1.8 %

Shares of LFWD stock opened at $2.24 on Friday. The company has a market cap of $19.65 million, a P/E ratio of -0.73 and a beta of 2.02. The firm has a fifty day moving average price of $2.97 and a 200 day moving average price of $3.85. ReWalk Robotics has a 12 month low of $2.20 and a 12 month high of $9.10.

ReWalk Robotics (NASDAQ:LFWD) last released its quarterly earnings data on Thursday, August 15th. The company reported ($0.50) EPS for the quarter, beating analysts’ consensus estimates of ($0.53) by $0.03. The business had revenue of $6.71 million for the quarter, compared to the consensus estimate of $6.71 million. ReWalk Robotics had a negative return on equity of 41.89% and a negative net margin of 102.03%. During the same quarter in the prior year, the business posted ($0.35) EPS. On average, equities analysts forecast that ReWalk Robotics will post -1.65 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright boosted their target price on ReWalk Robotics from $9.00 to $13.00 and gave the stock a “buy” rating in a research note on Friday, August 16th.

Institutional Trading of ReWalk Robotics

A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP purchased a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics at the end of the most recent reporting period. Hedge funds and other institutional investors own 26.76% of the company’s stock.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.